Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Clinical trial NCT00004635 · COMPLETED

Trial details

NCT number: NCT00004635
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2000-03-01
Primary completion: 2005-01-30
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.